Multivendor comparison of global and regional 2D cardiovascular magnetic resonance feature tracking strains vs tissue tagging at 3T.
Feature tracking
Magnetic resonance imaging
Strain
Tagging
Journal
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
ISSN: 1532-429X
Titre abrégé: J Cardiovasc Magn Reson
Pays: England
ID NLM: 9815616
Informations de publication
Date de publication:
13 05 2021
13 05 2021
Historique:
received:
07
05
2020
accepted:
16
03
2021
entrez:
13
5
2021
pubmed:
14
5
2021
medline:
29
10
2021
Statut:
epublish
Résumé
Cardiovascular magnetic resonance (CMR) 2D feature tracking (FT) left ventricular (LV) myocardial strain has seen widespread use to characterize myocardial deformation. Yet, validation of CMR FT measurements remains scarce, particularly for regional strain. Therefore, we aimed to perform intervendor comparison of 3 different FT software against tagging. In 61 subjects (18 healthy subjects, 18 patients with chronic myocardial infarction, 15 with dilated cardiomyopathy, and 10 with LV hypertrophy due to hypertrophic cardiomyopathy or aortic stenosis) were prospectively compared global (G) and regional transmural peak-systolic Lagrangian longitudinal (LS), circumferential (CS) and radial strains (RS) by 3 FT software (cvi42, Segment, and Tomtec) among each other and with tagging at 3T. We also evaluated the ability of regional LS, CS, and RS by different FT software vs tagging to identify late gadolinium enhancement (LGE) in the 18 infarct patients. GLS and GCS by all 3 software had an excellent agreement among each other (ICC = 0.94-0.98 for GLS and ICC = 0.96-0.98 for GCS respectively) and against tagging (ICC = 0.92-0.94 for GLS and ICC = 0.88-0.91 for GCS respectively), while GRS showed inconsistent agreement between vendors (ICC 0.10-0.81). For regional LS, the agreement was good (ICC = 0.68) between 2 vendors but less vs the 3 We confirm good agreement of CMR FT and little intervendor difference for GLS and GCS evaluation, with variable agreement for GRS. For regional strain evaluation, intervendor difference was larger, especially for RS, and the diagnostic performance varied more substantially among different vendors for regional strain analysis.
Sections du résumé
BACKGROUND
Cardiovascular magnetic resonance (CMR) 2D feature tracking (FT) left ventricular (LV) myocardial strain has seen widespread use to characterize myocardial deformation. Yet, validation of CMR FT measurements remains scarce, particularly for regional strain. Therefore, we aimed to perform intervendor comparison of 3 different FT software against tagging.
METHODS
In 61 subjects (18 healthy subjects, 18 patients with chronic myocardial infarction, 15 with dilated cardiomyopathy, and 10 with LV hypertrophy due to hypertrophic cardiomyopathy or aortic stenosis) were prospectively compared global (G) and regional transmural peak-systolic Lagrangian longitudinal (LS), circumferential (CS) and radial strains (RS) by 3 FT software (cvi42, Segment, and Tomtec) among each other and with tagging at 3T. We also evaluated the ability of regional LS, CS, and RS by different FT software vs tagging to identify late gadolinium enhancement (LGE) in the 18 infarct patients.
RESULTS
GLS and GCS by all 3 software had an excellent agreement among each other (ICC = 0.94-0.98 for GLS and ICC = 0.96-0.98 for GCS respectively) and against tagging (ICC = 0.92-0.94 for GLS and ICC = 0.88-0.91 for GCS respectively), while GRS showed inconsistent agreement between vendors (ICC 0.10-0.81). For regional LS, the agreement was good (ICC = 0.68) between 2 vendors but less vs the 3
CONCLUSIONS
We confirm good agreement of CMR FT and little intervendor difference for GLS and GCS evaluation, with variable agreement for GRS. For regional strain evaluation, intervendor difference was larger, especially for RS, and the diagnostic performance varied more substantially among different vendors for regional strain analysis.
Identifiants
pubmed: 33980259
doi: 10.1186/s12968-021-00742-3
pii: 10.1186/s12968-021-00742-3
pmc: PMC8117295
doi:
Substances chimiques
Contrast Media
0
Gadolinium
AU0V1LM3JT
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
54Références
J Am Soc Echocardiogr. 2015 Feb;28(2):183-93
pubmed: 25623220
J Cardiovasc Magn Reson. 2018 Sep 13;20(1):63
pubmed: 30208894
Int J Cardiovasc Imaging. 2018 Jan;34(1):27-33
pubmed: 27743139
J Cardiovasc Magn Reson. 2018 Apr 19;20(1):26
pubmed: 29669563
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 1):196-205
pubmed: 28528164
Circulation. 1996 Jun 15;93(12):2128-34
pubmed: 8925581
Eur Radiol. 2019 Dec;29(12):6846-6857
pubmed: 31297633
J Am Soc Echocardiogr. 2015 Oct;28(10):1171-1181, e2
pubmed: 26209911
J Cardiovasc Magn Reson. 2014 Jan 22;16:10
pubmed: 24450803
J Magn Reson Imaging. 2015 Apr;41(4):1000-12
pubmed: 24677420
Eur Radiol. 2018 Dec;28(12):5137-5147
pubmed: 29872912
PLoS One. 2018 Mar 14;13(3):e0193746
pubmed: 29538467
Int J Cardiol. 2015 Mar 1;182:342-348
pubmed: 25590963
Circ Cardiovasc Imaging. 2017 Nov;10(11):
pubmed: 29138230
JACC Cardiovasc Imaging. 2015 Aug;8(8):934-46
pubmed: 26189121
Int J Cardiovasc Imaging. 2012 Dec;28(8):2009-18
pubmed: 22392105
J Am Soc Echocardiogr. 2012 Nov;25(11):1195-203
pubmed: 22981228
JACC Cardiovasc Imaging. 2018 Oct;11(10):1419-1429
pubmed: 29361479
J Cardiovasc Magn Reson. 2013 Jan 18;15:8
pubmed: 23331550
Eur Heart J Cardiovasc Imaging. 2019 Jun 1;20(6):605-619
pubmed: 30903139
J Am Soc Echocardiogr. 2015 Jun;28(6):630-41
pubmed: 25747915
JACC Cardiovasc Imaging. 2015 May;8(5):540-549
pubmed: 25890580
JACC Cardiovasc Imaging. 2015 Dec;8(12):1444-1460
pubmed: 26699113
Int J Cardiol. 2017 Oct 1;244:340-346
pubmed: 28624332
JACC Cardiovasc Imaging. 2010 Feb;3(2):144-51
pubmed: 20159640
Pediatr Radiol. 2014 Sep;44(9):1070-6
pubmed: 24760125
ESC Heart Fail. 2020 Apr;7(2):523-532
pubmed: 31800152
J Magn Reson Imaging. 2015 Apr;41(4):1129-37
pubmed: 24700404
Eur Heart J Cardiovasc Imaging. 2020 Aug 13;:
pubmed: 32793957
Int J Cardiol. 2017 Apr 1;232:336-341
pubmed: 28153537
J Cardiovasc Magn Reson. 2016 Jun 07;18(1):36
pubmed: 27268238
J Cardiovasc Magn Reson. 2012 Jun 21;14:43
pubmed: 22721175
Eur J Radiol. 2019 Apr;113:51-58
pubmed: 30927959
Eur Heart J Cardiovasc Imaging. 2015 Aug;16(8):871-81
pubmed: 25711353
Eur Heart J Cardiovasc Imaging. 2012 Jul;13(7):617-23
pubmed: 22271116